Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-22 @ 4:14 AM
Study NCT ID:
NCT02685059
Status:
COMPLETED
Last Update Posted:
2021-02-15
First Post:
2016-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer
Sponsor:
GBG Forschungs GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-14
First Submit QC Date:
None
Study First Post Date:
2016-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-11
Last Update Post Date:
2021-02-15
Last Update Post Date Type:
ACTUAL